Alzheimer’s disease, the most common form of dementia, affects millions of older adults worldwide. It causes memory loss, cognitive decline, and behavioral changes, significantly impacting the lives of patients and their families.
Despite decades of research, there is still no cure, and treatments only manage symptoms rather than halting or reversing the disease. Scientists continue to search for answers, and a new study may provide a promising breakthrough.
For years, researchers have debated the root cause of Alzheimer’s. Two main theories dominate the discussion. The first attributes the disease to the buildup of a protein called amyloid-beta in the brain.
These protein clumps, or plaques, interfere with the communication between brain cells. The second, newer theory focuses on metabolic dysfunction, particularly problems with mitochondria—the energy-producing structures in cells.
A groundbreaking study from Yale-NUS College, led by Jan Gruber, lends support to the metabolic dysfunction theory. The researchers used Caenorhabditis elegans worms, a model organism with cellular processes similar to humans, to study the disease.
They observed that metabolic problems appeared in the worms before amyloid-beta protein began accumulating. This suggests that disrupted energy production in cells might be a key factor in the early stages of Alzheimer’s.
One of the most intriguing findings of the study involves Metformin, a drug widely used to treat diabetes. When the researchers gave Metformin to the worms, it corrected the metabolic defects and restored their health and lifespan to normal.
This result points to a potential new approach for preventing Alzheimer’s—targeting mitochondrial and metabolic health rather than focusing solely on amyloid-beta buildup.
The implications of this study extend beyond Alzheimer’s disease. The researchers propose that age-related diseases, including Alzheimer’s, might not be separate conditions but rather signs of the aging process itself. If so, tackling the root causes of aging—such as declining mitochondrial function—could prevent or treat multiple diseases simultaneously.
While the findings are promising, much work remains. The next steps involve testing Metformin or similar treatments in human studies to determine their safety and effectiveness for Alzheimer’s patients.
This study, published in the journal eLife, opens the door to new ways of thinking about Alzheimer’s and aging-related diseases.
Although Alzheimer’s disease remains a challenging puzzle, research like this brings us closer to understanding its underlying mechanisms.
By focusing on the connection between metabolism and brain health, scientists may uncover more effective strategies to slow or prevent the disease. For now, this study offers a hopeful glimpse into the future of Alzheimer’s research and treatment.
If you care about Alzheimer’s, please read studies about the likely cause of Alzheimer’s disease and new non-drug treatment that could help prevent Alzheimer’s.
For more information about brain health, please see recent studies about diet that may help prevent Alzheimer’s, and results showing some dementia cases could be prevented by changing these 12 things.
Copyright © 2025 Knowridge Science Report. All rights reserved.
